ArticleCureus2026
Do Popular Physician-Rating Websites Provide Consistent Reviews for Academic and Community Hematology-Oncology Physicians?
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPhysician-rating websites are frequently used by patients and health systems seeking information about clinicians, but the reliability of these data for hematology-oncology physicians is unclear.
objectiveTo evaluate review volume, rating scores, and physician-level associations on popular physician-rating websites for academic and community hematology-oncology physicians.
methodsWe conducted a retrospective cross-sectional analysis of 210 US hematology-oncology attending physicians, including 105 academic and 105 community/private physicians. Academic physicians were sampled from 21 academic cancer-center sampling blocks across five US regions, including four blocks each from the Northeast, Southeast, Midwest, and Southwest, and five from the West. Community/private physicians were sampled from nearby non-academic hospitals or oncology practices in the same geographic areas. Fellows, residents, advanced practice providers, non-attending physicians, and pediatric-only oncologists were excluded. Physician-rating data were collected from Healthgrades, Vitals, RateMDs, and WebMD. Continuous variables were summarized using means with standard deviations and medians with interquartile ranges. Academic and community physicians were compared using Mann-Whitney U tests for skewed continuous variables and chi-square tests for categorical variables. Associations between years in practice, review volume, and ratings were assessed using Spearman correlation. A blinded second reviewer abstracted a subset of physicians to assess interrater reliability.
resultsAmong 210 hematology-oncology physicians, the mean total number of reviews across all four websites was 40.3 ± 99.7, with a median of 14.0 reviews (interquartile range (IQR): 4.0-38.8) and a range of 0-1030. Nine physicians (4.3%) had zero reviews, 63 (30.0%) had fewer than five reviews, and 83 (39.5%) had fewer than 10 reviews. Community/private physicians had higher review volume than academic physicians, with 56.0 ± 126.8 reviews vs. 24.6 ± 58.3 reviews, and median review counts of 24.0 (IQR: 5.0-55.0) vs. 10.0 (IQR: 3.0-25.0) (p = 0.0014). Academic physicians were more likely than community/private physicians to have fewer than 10 total reviews: 52/105 (49.5%) vs. 31/105 (29.5%) (p = 0.003). Among physicians with at least one available platform rating, the mean rating score was 4.39 ± 0.78 on a 1-5 scale. Mean rating scores were 4.51 ± 0.56 for community/private physicians and 4.28 ± 0.93 for academic physicians, but rating distributions did not differ significantly by cohort (p = 0.47). No meaningful gender-based differences were identified. Longer time in practice was associated with greater total review volume (Spearman's ρ = 0.379, p < 0.001) and lower mean rating scores (ρ = -0.255, p < 0.001). Interrater agreement was near-perfect across review presence, number of reviews, rating presence, average rating scores, and narrative comment presence, with kappa values ranging from 0.94 to 0.96.
conclusionPopular physician-rating websites offer limited, highly variable review volume for hematology-oncology physicians, with many clinicians receiving few or no reviews despite generally high average ratings. Community/private physicians had more reviews than academic physicians, while rating distributions were similarly high across cohorts. These results indicate that online physician ratings should be interpreted cautiously by patients, clinicians, and health systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.